ArhGAP11A mediates amyloid-β generation and neuropathology in an Alzheimer’s disease-like mouse model

Summary: Amyloid-β (Aβ) plays an important role in the neuropathology of Alzheimer’s disease (AD), but some factors promoting Aβ generation and Aβ oligomer (Aβo) neurotoxicity remain unclear. We here find that the levels of ArhGAP11A, a Ras homology GTPase-activating protein, significantly increase...

Full description

Bibliographic Details
Main Authors: Ya-ru Huang, Xi-xiu Xie, Jing Yang, Xiao-ying Sun, Xiao-yun Niu, Cheng-gang Yang, Ling-jie Li, Lun Zhang, Dan Wang, Chun-yu Liu, Sheng-jie Hou, Chen-yang Jiang, Yu-ming Xu, Rui-tian Liu
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124723006356
_version_ 1797807023102885888
author Ya-ru Huang
Xi-xiu Xie
Jing Yang
Xiao-ying Sun
Xiao-yun Niu
Cheng-gang Yang
Ling-jie Li
Lun Zhang
Dan Wang
Chun-yu Liu
Sheng-jie Hou
Chen-yang Jiang
Yu-ming Xu
Rui-tian Liu
author_facet Ya-ru Huang
Xi-xiu Xie
Jing Yang
Xiao-ying Sun
Xiao-yun Niu
Cheng-gang Yang
Ling-jie Li
Lun Zhang
Dan Wang
Chun-yu Liu
Sheng-jie Hou
Chen-yang Jiang
Yu-ming Xu
Rui-tian Liu
author_sort Ya-ru Huang
collection DOAJ
description Summary: Amyloid-β (Aβ) plays an important role in the neuropathology of Alzheimer’s disease (AD), but some factors promoting Aβ generation and Aβ oligomer (Aβo) neurotoxicity remain unclear. We here find that the levels of ArhGAP11A, a Ras homology GTPase-activating protein, significantly increase in patients with AD and amyloid precursor protein (APP)/presenilin-1 (PS1) mice. Reducing the ArhGAP11A level in neurons not only inhibits Aβ generation by decreasing the expression of APP, PS1, and β-secretase (BACE1) through the RhoA/ROCK/Erk signaling pathway but also reduces Aβo neurotoxicity by decreasing the expressions of apoptosis-related p53 target genes. In APP/PS1 mice, specific reduction of the ArhGAP11A level in neurons significantly reduces Aβ production and plaque deposition and ameliorates neuronal damage, neuroinflammation, and cognitive deficits. Moreover, Aβos enhance ArhGAP11A expression in neurons by activating E2F1, which thus forms a deleterious cycle. Our results demonstrate that ArhGAP11A may be involved in AD pathogenesis and that decreasing ArhGAP11A expression may be a promising therapeutic strategy for AD treatment.
first_indexed 2024-03-13T06:16:16Z
format Article
id doaj.art-0fc98a5893394101a62f5db921a73f36
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-03-13T06:16:16Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-0fc98a5893394101a62f5db921a73f362023-06-11T04:14:28ZengElsevierCell Reports2211-12472023-06-01426112624ArhGAP11A mediates amyloid-β generation and neuropathology in an Alzheimer’s disease-like mouse modelYa-ru Huang0Xi-xiu Xie1Jing Yang2Xiao-ying Sun3Xiao-yun Niu4Cheng-gang Yang5Ling-jie Li6Lun Zhang7Dan Wang8Chun-yu Liu9Sheng-jie Hou10Chen-yang Jiang11Yu-ming Xu12Rui-tian Liu13State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, ChinaDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; Henan Medical Key Laboratory of Neurogenetic and Neurodegenerative Disease, Zhengzhou 450052, Henan, ChinaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; Ningxia University, Yinchuan 750021, Ningxia, ChinaDepartment of BigData, Beijing Medintell Bioinformatic Technology Co., Ltd., Beijing 100081, China; Department of Research and Development, Gu’an Bojian Bio-Technology Co., Ltd., Langfang 065000, Hebei, ChinaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, ChinaDepartment of BigData, Beijing Medintell Bioinformatic Technology Co., Ltd., Beijing 100081, ChinaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; Shandong Agricultural University, Tai’an 271000, Shandong, ChinaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDepartment of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; Key Laboratory of Cerebrovascular Disease of Henan Province, Zhengzhou 450052, Henan, China; Corresponding authorState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; Corresponding authorSummary: Amyloid-β (Aβ) plays an important role in the neuropathology of Alzheimer’s disease (AD), but some factors promoting Aβ generation and Aβ oligomer (Aβo) neurotoxicity remain unclear. We here find that the levels of ArhGAP11A, a Ras homology GTPase-activating protein, significantly increase in patients with AD and amyloid precursor protein (APP)/presenilin-1 (PS1) mice. Reducing the ArhGAP11A level in neurons not only inhibits Aβ generation by decreasing the expression of APP, PS1, and β-secretase (BACE1) through the RhoA/ROCK/Erk signaling pathway but also reduces Aβo neurotoxicity by decreasing the expressions of apoptosis-related p53 target genes. In APP/PS1 mice, specific reduction of the ArhGAP11A level in neurons significantly reduces Aβ production and plaque deposition and ameliorates neuronal damage, neuroinflammation, and cognitive deficits. Moreover, Aβos enhance ArhGAP11A expression in neurons by activating E2F1, which thus forms a deleterious cycle. Our results demonstrate that ArhGAP11A may be involved in AD pathogenesis and that decreasing ArhGAP11A expression may be a promising therapeutic strategy for AD treatment.http://www.sciencedirect.com/science/article/pii/S2211124723006356CP: Neuroscience
spellingShingle Ya-ru Huang
Xi-xiu Xie
Jing Yang
Xiao-ying Sun
Xiao-yun Niu
Cheng-gang Yang
Ling-jie Li
Lun Zhang
Dan Wang
Chun-yu Liu
Sheng-jie Hou
Chen-yang Jiang
Yu-ming Xu
Rui-tian Liu
ArhGAP11A mediates amyloid-β generation and neuropathology in an Alzheimer’s disease-like mouse model
Cell Reports
CP: Neuroscience
title ArhGAP11A mediates amyloid-β generation and neuropathology in an Alzheimer’s disease-like mouse model
title_full ArhGAP11A mediates amyloid-β generation and neuropathology in an Alzheimer’s disease-like mouse model
title_fullStr ArhGAP11A mediates amyloid-β generation and neuropathology in an Alzheimer’s disease-like mouse model
title_full_unstemmed ArhGAP11A mediates amyloid-β generation and neuropathology in an Alzheimer’s disease-like mouse model
title_short ArhGAP11A mediates amyloid-β generation and neuropathology in an Alzheimer’s disease-like mouse model
title_sort arhgap11a mediates amyloid β generation and neuropathology in an alzheimer s disease like mouse model
topic CP: Neuroscience
url http://www.sciencedirect.com/science/article/pii/S2211124723006356
work_keys_str_mv AT yaruhuang arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT xixiuxie arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT jingyang arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT xiaoyingsun arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT xiaoyunniu arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT chenggangyang arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT lingjieli arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT lunzhang arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT danwang arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT chunyuliu arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT shengjiehou arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT chenyangjiang arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT yumingxu arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel
AT ruitianliu arhgap11amediatesamyloidbgenerationandneuropathologyinanalzheimersdiseaselikemousemodel